PC
GRTS

PointState Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

PointState Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-130,000
Closed -$1.85M – 144
2018
Q3 		$1.85M Buy
+130,000
New +$1.85M 0.02% 118

Other funds holding GRTS

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital's GRTS Position: Q4 2018 in Review

PointState Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2018, closing a stake of 130,000 shares — an estimated $1.85M sold.

PointState Capital first reported a position in GRTS in Q3 2018 and held it in 1 quarter. The position peaked at $1.85M in Q3 2018. 52 funds tracked by Wall St. Rank hold GRTS as of Q4 2018.

  • PointState Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • PointState Capital sold 130,000 Gritstone bio, Inc. Common Stock shares in Q4 2018, an estimated $1.85M.
  • PointState Capital first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • PointState Capital's Gritstone bio, Inc. Common Stock position peaked at $1.85M in Q3 2018.
  • 52 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2018.

Based on PointState Capital's 13F filing for Q4 2018, filed 14 Feb 2019.